FindTrial
Sign In

Reserch on neonate respiratory distress syndrome

Reserch on the Improvement of “InSurE”strategy in neonate respiratory distress syndrome.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014527
Enrollment
Unknown
Registered
2018-01-18
Start date
2018-01-06
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal respiratory distress syndrome

Interventions

new InSureE:Improvement of InSurE technique
control group:InSureE technique

Sponsors

First affiliated hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Premature infants of <36 weeks gestation with birth weight <2500 g; 2) Clinical or radiographic evidence of RDS that had been established or the infants with early symptons of high risk of RDS; 3) Approved by the sponsor Ethics Committee of the First affiliated hospital of Nanjing Medical University; 4) Informed written parental consent is required.

Exclusion criteria

Exclusion criteria: 1) Major congenital abnormalities considered to be life threatening (Down's syndrome,diaphragmatic hernias and congenital digestive deformity etc.); 2) Cyanotic congenital heart disease interfering with hemodynamic lung development or function (such as transposition of the great arteries and tetralogy of Fallot etc.); 3) Congenital heredity metabolic disease; 4)Informed written parental consent is not acquired from parents.

Design outcomes

Primary

MeasureTime frame
mortality rate;duration of mechanical ventilation;—

Countries

China

Contacts

Public ContactChen Xiaoqing

First affiliated hospital of Nanjing Medical University

chenxq2002@foxmail.com+86 13951676702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026